Favorable Figures and a New Collaboration: Ocugen Shows How to End the Week in Style
OCGN

This week Ocugen, Inc. ($OCGN) entered into an agreement with Kemwell Biopharma for the cGMP production of OCU200. This is the new biologic product candidate in preclinical development for the treatment of severe vision-threatening diseases, such as: diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (Wet-AMD). What is the power of…

Tilray, Inc +18%: When Promising Test Results and Cannabis Decriminalization converge
TLRY

Tilray, Inc. ($TLRY) is hugely supported after Kamala Harris announced that Biden‘s government wants to decriminalize cannabis. Legalization of medical cannabis helps destigmatize related products. It also discussed the possible deletion of files of those convicted of cannabis possession. The shares of various cannabis companies enjoyed a nice jump today, causing the share of Tilray…

Why are Medical Reseachers Thrilled about the New Technologies of Pressure BioSciences?
PBIO

Breakout Stocks   Corona Virus Stocks Not everyone will already be familiar with “nano-emulsification technology“. But Pressure BioSciences, Inc. (OTCQB: PBIO) has made a revolutionary development with this. The company is now entering the commercial system development era of the production. In addition to this development, final design specifications are currently being finalized, the first build of…